Here is the full medical record in chat:
INTERNAL MEDICINE CASE RECORD
(Endocrinology / Lipid Clinic)
I. ADMINISTRATIVE INFORMATION
Full name: [Patient name on file]
Sex: Female
Age: [Age on file]
Address: [Address on file]
Ethnicity: [On file]
Occupation: [On file]
Date and time of admission: [Date on file]
Date of medical record: July 02, 2026
Referral source: Referred by Dr. Chong Kim
II. MEDICAL RECORD SECTION
1. Reason for Admission
Dyslipidemia (high blood cholesterol) detected on routine health check-up, with associated history of abdominal pain and weight loss.
2. History of Present Illness
The patient is a female presenting with dyslipidemia identified during a routine health check. She has a known history of high blood cholesterol for which she has been taking cholesterol-lowering medication, and attends clinic follow-up monthly. She was previously admitted for 5 days in relation to this condition.
She had a prior history of abdominal (stomach) pain which prompted weight loss and medical evaluation; there is currently no active abdominal pain. She reports no pain after consuming fatty foods and no nausea or vomiting. She also has a history of thyroid disease (around August of last year) and Type 2 Diabetes Mellitus diagnosed approximately one year ago, for which she is currently on diabetes medication.
She denies muscle pain or weakness while taking statin therapy. Urinary frequency is approximately 3 times per day. She has reached menopause.
Condition on Presentation:
- High blood cholesterol - dyslipidemia on routine screening
- Xanthelasma present
- Cardiovascular symptoms: chest pain, dyspnea on exertion, palpitations, intermittent leg pain on walking
- Menopausal status
Current Medications on Admission:
- Cholesterol-lowering medication (statin - specific drug not documented)
- Diabetes medication (specific drug not documented)
Hospital Course:
Cholesterol levels were checked 5 days prior to this visit. The patient denies any muscle pain, weakness, or back pain during the current presentation. She reports no swelling, no jaundice, and no liver-related symptoms. Sleep is not disturbed. She eats 3 meals per day.
Current Status: The patient is conscious and cooperative. She has no active abdominal pain. Cardiovascular symptoms (chest pain, exertional dyspnea, palpitations, and claudication-type leg pain) are present. Xanthelasma is noted. No tendon xanthomas. No muscle symptoms from current lipid-lowering therapy.
3. Past Medical History
Personal History
Internal Medicine:
- Dyslipidemia - on cholesterol-lowering medication; monthly follow-up
- Type 2 Diabetes Mellitus - diagnosed approximately 1 year ago; on diabetes medication
- Thyroid disease - diagnosed around August of last year
- Nephrolithiasis (kidney stones) - previously diagnosed; presented with lower abdominal pain
Habits:
- Diet: high saturated fat intake; reduced sugar intake
- Alcohol: does not consume alcohol
- Smoking: not documented
Allergies:
- No known drug allergies documented
- No known food allergies documented
Family History:
- Mother with high cholesterol (dyslipidemia)
- High cholesterol in other first-degree relatives
- Recurrent pancreatitis in family members
4. Physical Examination
General Examination
Vital Signs on Admission:
- Heart rate: [on file] beats/minute
- Blood pressure: [on file] mmHg
- Respiratory rate: [on file] breaths/minute
- Temperature: [on file] °C
- Weight: [on file] kg; Height: [on file] cm; BMI: [on file]
General Condition:
- Conscious and oriented
- No jaundice
- No oedema
- No fever
- Appetite normal (3 meals/day)
- Sleep not disturbed
- Menopausal
Dermatological Examination:
- Xanthelasma present (periorbital)
- No tendon xanthomas
- No eruptive xanthomas
- No skin pain
Cardiovascular Examination:
- Chest pain reported by patient
- Dyspnea on exertion present
- Palpitations reported
- Intermittent leg pain on walking (claudication pattern)
- Pulse: [on file]
- Heart sounds S1 and S2: [on file]
- No murmur documented
Abdominal Examination:
- No current abdominal pain
- No pain after eating fatty foods
- No acute epigastric pain radiating to the back
- No nausea or vomiting
- Abdomen: soft/non-tender (to be confirmed)
- No palpable organomegaly documented
Thyroid Examination:
- History of thyroid disease; thyroid findings on examination: [to be documented]
Renal / Urinary Examination:
- History of kidney stones
- Current urinary frequency: approximately 3 times/day (normal)
- No dysuria or urinary complaints currently
Pancreatitis Assessment:
- No acute epigastric pain
- No nausea or vomiting
- No current features of acute pancreatitis
- Family history of recurrent pancreatitis noted
Musculoskeletal / Neurological Examination:
- No muscle pain
- No muscle weakness
- No back pain
- Leg pain on walking (possible peripheral vascular origin)
Other Systems:
- Respiratory: no abnormal findings documented
- No liver disease symptoms
5. Case Summary
A female patient of menopausal age presented for a routine health check-up during which dyslipidemia (high blood cholesterol) was detected. She has been on cholesterol-lowering medication and attends monthly clinic follow-up. She has a background history of Type 2 Diabetes Mellitus (diagnosed approximately 1 year ago), prior thyroid disease, kidney stones, and a previous episode of abdominal pain associated with weight loss (now resolved). Her mother had the same lipid disorder. Family history is notable for first-degree relatives with high cholesterol and recurrent pancreatitis.
On review of systems, the patient reports cardiovascular symptoms including chest pain, dyspnea on exertion, palpitations, and claudication-type leg pain while walking. Xanthelasma is present on examination. There are no tendon xanthomas, no active abdominal pain, and no statin-related myopathy symptoms. She does not consume alcohol. Her diet is high in saturated fat with reduced sugar. She has reached menopause.
Subjective Symptoms:
- High blood cholesterol (dyslipidemia) on routine screening
- Chest pain
- Shortness of breath on exertion
- Palpitations
- Leg pain while walking
- Prior abdominal pain (now resolved)
- Weight loss (prior)
Objective Findings:
- Xanthelasma present
- No tendon xanthomas
- No active abdominal signs
- No statin-related myopathy
- Elevated cholesterol on blood tests (5 days prior)
Past History:
- Dyslipidemia - on treatment
- Type 2 Diabetes Mellitus
- Thyroid disease (around August last year)
- Kidney stones
6. Problem List
- Dyslipidemia - elevated total cholesterol / LDL (primary concern)
- Cardiovascular symptoms (chest pain, exertional dyspnea, palpitations, claudication)
- Xanthelasma
- Type 2 Diabetes Mellitus
- Thyroid disease (previous; status under review)
- Nephrolithiasis (history)
- High saturated fat diet
- Positive family history of dyslipidemia and pancreatitis
- Menopausal status (risk factor for dyslipidemia)
7. Diagnosis
Preliminary Diagnosis:
Dyslipidemia (mixed/hypercholesterolaemia - to be classified after full lipid panel)
Differential Diagnosis:
- Primary (familial) hypercholesterolaemia - given strong family history and xanthelasma
- Secondary dyslipidemia due to hypothyroidism - prior thyroid disease must be excluded
- Secondary dyslipidemia due to Type 2 Diabetes Mellitus
- Mixed hyperlipidaemia (elevated LDL-C and triglycerides) with pancreatitis risk given family history
- Drug-induced dyslipidemia
8. Clinical Discussion
The preliminary diagnosis of dyslipidemia is supported by elevated cholesterol detected on routine blood work, the presence of xanthelasma (a cutaneous manifestation of hypercholesterolaemia), a strong family history of dyslipidemia (mother and first-degree relatives), and cardiovascular symptoms including chest pain, exertional dyspnea, palpitations, and claudication - all suggestive of atherosclerotic cardiovascular disease burden.
Secondary causes must be systematically excluded. The patient has a prior history of thyroid disease; hypothyroidism is a well-recognised cause of secondary dyslipidemia and must be evaluated with current thyroid function tests. Type 2 Diabetes Mellitus is another important secondary contributor, characteristically producing elevated triglycerides and low HDL-C. Renal causes are relevant given her history of kidney stones, though nephrolithiasis itself does not directly cause dyslipidemia.
The family history of recurrent pancreatitis raises the possibility of a familial hypertriglyceridaemia syndrome, which would significantly alter management. The diet history (high saturated fat) is a modifiable risk factor. Menopausal status is also associated with an adverse lipid profile shift.
No statin-induced myopathy is evident. The patient does not consume alcohol, which excludes alcohol-induced hypertriglyceridaemia. There are no features of acute pancreatitis at this visit.
Cardiovascular risk stratification is required using a validated tool (e.g., SCORE2, Framingham, or Thai-specific risk calculator) incorporating her diabetes, lipid levels, menopausal status, and existing symptoms to determine LDL-C target and treatment intensity.
9. Recommended Investigations and Available Results
Available Results:
- Fasting lipid panel (checked 5 days prior): Total cholesterol elevated (full values pending record review); LDL-C, HDL-C, and triglycerides to be documented
Recommended Investigations:
Haematology:
- Complete blood count (CBC)
Biochemistry:
- Fasting lipid profile: Total cholesterol, LDL-C, HDL-C, triglycerides, non-HDL-C
- Fasting blood glucose and HbA1c (diabetes monitoring)
- Thyroid function tests: TSH, free T4 (to exclude hypothyroidism as secondary cause)
- Renal function: serum creatinine, eGFR, urea (history of kidney stones)
- Liver function tests: AST, ALT, ALP (baseline before statin therapy and to exclude hepatic causes)
- Creatine kinase (CK) - baseline statin monitoring (no current myopathy)
- Uric acid (pancreatitis risk panel)
- Electrolytes: Na, K
Urinalysis:
- Urine dipstick and microscopy (history of kidney stones)
- Urine protein/creatinine ratio
Imaging:
- Abdominal ultrasonography (liver, gallbladder, kidney - history of kidney stones and prior abdominal pain)
- ECG (cardiovascular symptoms: chest pain, palpitations)
- Consider echocardiogram and stress testing given exertional dyspnea and chest pain
- Ankle-brachial index (ABI) for claudication assessment
Interpretation of Investigation Results (Pending):
- Elevated total cholesterol confirmed on prior blood test - full lipid profile values awaited
- Thyroid status must be interpreted to exclude secondary dyslipidemia
- Liver and renal function needed to guide statin dosing and safety
- CK baseline required before intensifying statin therapy
Definitive Diagnosis:
- Dyslipidemia (hypercholesterolaemia) - to be further classified as primary vs. secondary once workup is complete
Comorbidities:
- Type 2 Diabetes Mellitus
- Thyroid disease (prior)
- Nephrolithiasis (prior)
10. Treatment
A. Non-Pharmacological Treatment:
- Educate the patient and family about dyslipidemia, cardiovascular risk, treatment goals, medication adherence, and follow-up requirements
- Therapeutic lifestyle changes (TLC):
- Reduce saturated fat intake to <7% of total daily calories
- Eliminate trans-fatty acids from diet
- Increase dietary fibre (oats, legumes, vegetables)
- Reduce dietary cholesterol
- Maintain or achieve healthy body weight
- Regular aerobic exercise (150 minutes moderate intensity per week), adjusted for cardiovascular symptoms
- Encourage continued abstinence from alcohol
- Address menopausal status - cardiovascular risk counselling
- Monitor and manage associated conditions (diabetes, thyroid disease)
B. Pharmacological Treatment:
Lipid-Lowering Therapy:
- Continue current statin therapy (confirm agent and dose)
- Review LDL-C target based on cardiovascular risk category:
- High/very high risk (given symptoms, diabetes, family history): target LDL-C <1.4-1.8 mmol/L
- Consider intensifying statin dose or switching to high-intensity statin (atorvastatin 40-80 mg or rosuvastatin 20-40 mg)
- If LDL-C target not achieved on maximal statin: consider ezetimibe 10 mg daily as add-on therapy
- If triglycerides remain markedly elevated (>10 mmol/L): consider fibrate therapy to reduce pancreatitis risk
- Monitor for statin-related adverse effects: myalgia, elevated CK, transaminitis
Management of Diabetes:
- Continue current diabetes medication
- Aim for HbA1c <7.0% (or individualised target)
- Note: GLP-1 agonists and SGLT-2 inhibitors also carry cardiovascular and lipid benefits
Cardiovascular Risk Reduction:
- Investigate chest pain and exertional dyspnea urgently (ECG, stress test, cardiology review)
- Consider antiplatelet therapy (aspirin or clopidogrel) if established cardiovascular disease is confirmed
- Evaluate for peripheral artery disease (ankle-brachial index)
Thyroid Management:
- Check current thyroid status (TSH, free T4)
- If hypothyroidism confirmed: initiate or optimise levothyroxine therapy - lipid profile may improve with thyroid normalisation
Pre-treatment Screening / Safety Monitoring:
- CBC, liver function tests (AST, ALT), renal function (creatinine, eGFR), CK before intensifying therapy
- Hepatitis B and C screening prior to initiating or intensifying statin therapy
Monitoring Plan:
- Repeat fasting lipid panel at 6-8 weeks after medication adjustment
- Monitor liver enzymes and CK at baseline and at 6-12 weeks if dose is increased
- Monitor HbA1c and fasting glucose every 3 months
- Monthly clinic follow-up to be continued as per current practice
- Annual cardiovascular risk reassessment
Management of Comorbidities:
- Continue all current medications for diabetes and dyslipidemia
- Reassess thyroid medication if hypothyroidism is confirmed or worsening
- Urology/nephrology review for kidney stone history as appropriate
- Regular monitoring of blood glucose, HbA1c, lipid profile, thyroid function, and renal function
Note: Fields marked [on file] require completion from the original patient chart (exact age, full name, vital signs, specific lipid values).